Apple Tree Partners

Apple Tree Partners

$70,000,000 Venture capital (Series B)
PE HUB , FinSMEs

Akero Therapeutics locks in $70 mln Series B

$90,000,000 Venture capital (Series B)
FinSMEs , PE HUB

Stoke Therapeutics Raises $90M in Series B Financing

Funding Health
FinSMEs

Alexion To Acquire Syntimmune, for Up To $1.2 Billion

Health
$65,000,000 Venture capital (Series A)
FinSMEs

Akero Therapeutics Closes $65M Series A Financing

Funding Health Science
FinSMEs

Corvidia Therapeutics Secures $60M in Series B Funding

Funding Health
Bloomberg

Dermira Reminds Investors What Binary Means in Biotech

Stock markets Health
Xconomy

Dermira Abandons Acne Drug After Phase 3 Flops, Stock Price Craters

Health
FinSMEs

Stoke Therapeutics Raises $40M in Series A Financing

Science Health Funding
PE HUB

| Apple Tree-backed Syntimmune appoints president and CEO

Strategy Health
Xconomy

Dermira Commits $135M for Global Rights to Roche Eczema Drug

Health
Xconomy

Syntimmune Snares $50M to Test Autoimmune Drug in Two Rare Diseases

Health Science
$40,000,000 Venture capital (Series E)
FinSMEs

ROX Medical Raises $40M in Funding

Funding Health
$49,000,000 Venture capital (Series C)
prnewswire

VytronUS, Inc. Raises $49 Million in Series C Financing

$26,000,000 Venture capital (Series A)
VentureWire

The Daily Startup: Syntimmune Fights Autoimmune Diseases With New Funds

Funding
$26,000,000 Venture capital (Series A)
businesswire

Syntimmune Secures Second Tranche of $26 Million Series A Financing

Xconomy

NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree

Funding Health